biopôle clermont limagne emploi

BioFilm Control is rolling out clinical research protocols to validate its flagship product, the Antibiofilmogramme ® innovating diagnostic test ICARE is an international group with 4 specialized subsidiaries: Laboratoire ICARE, ICARE Validation, Laboratoire ICARE SWITZERLAND (in Switzerland) and MEDLAB (in Brazil). Its market is growing fast – at a projected 5% to 6% a year between now andToday’s main producers manufacture only the DLMethionine form through petrochemical processes, a form containing 50% of the natural LMethionine form and 50% of the non-natural D-Methionine form, this last being more difficult to assimilate by animals in their growth stage.Intended to prescribe better antibiotics, the Antibiofilmogramme ® takes into account at the same time classic resistances and those linked to the capacity of bacteria to form biofilms. It will also produce batches of monomers for technical and regulatory validation of recycled PET by future licensees.Greentech, a world leader in plant biotechnology that produces ingredients for the cosmetics, pharmacy and nutrition sectors, recently teamed up with the ECREIN team of the Human Nutrition Unit at the Université Clermont Auvergne (UCA) and INRAE, known for its expertise in the study of immunocompetent cells.These two partners have joined forces to create a joint public-private laboratory (Labcom) funded by the Agence Nationale de la Recherche (ANR).

"All the aspects of sterilization”: ICARE organizes a day on the sterilization of medical devices Carried out over 5 years, this collaborative project has just been successfully completed in accordance with the initial timing and objectives.During the final key stage, CARBIOS published several announcements on successful developments of its technologies. "Piloter sa ferme" is a solution tailored to the needs of farmers in search of an effective sales management. CARBIOS successfully completes final key stage of the THANAPLAST™ project and receives €1 million from Bpifrance.

The molecule is indeed able to promote the regrowth of nerve fibbers and the establishment of connections so favouring a significant functional covering to the hurt animal. The Company, based at the Biopôle of Clermont-Limagne, Saint-Beauzire (France), realized a major industrial proof-of-concept through the validation of its fermenting technology with 70 000 liters.The erected platform, located at Cristal Union’s site in Clermont-Ferrand, led to the production of “hundreds of kilograms » of bio-based organic acids from « tons of sugar-based by-products. The degree of purity of the obtained molecules is in compliance with the requirements of the market and were certified 100 % from organic-source according to existing standards.

Between research and ecological engineering, it offers independant expertise based on both scientifical and naturalist approach of ecology.The Crexeco expertise concerns natural environments and, take the form of various fields like regulatory studies, applied research and teaching.From preliminary studies to ecological monitoring of infrastructures and wildlife inventories, Crexeco supports any project leader in successive steps of the project.It also develop applied research studies allowing to answer to crucial questions posed to project leaders and public authorities.Finally Crexeco promotes the diffusion of knowledge by teaching on ecology and wildife conservation, and reading specialized litterature. With Soludiag and Nanosolution, Aptys Pharmaservices evaluates and improves the solubility and availability of active ingredients.

Created in 1995, Icare laboratories built in 2002 their premises on the Biopole Clermont-Limagne, Saint-Beauzire: 2000 m2 which the company intends to carry in 6000 m2 within the next 10 years, through an ambitious development plan which aims at tripling the capacity of the company. The company has also acquired in 2012 the company QUALISTE, based itself in Montpellier.

Bio-entrepreneurs, on the way to Auvergne Nanosolution has the advantage of being able to test many compositions in a single step and using little material.AFYREN has successfully gathered 12 key bioeconomy players around a new European project to develop the first of its kind flagship biorefinery in France.AFYREN meets a growing need among businesses and industries to reduce the use of petroleum-based products in their production lines. GREENTECH is closely working with the University of Antsiranana. Intercompanies day-nursery, company restaurant, public transport: employee services are being put in place in the Saint-Beauzire site With this new organization, Cyclopharma is committed to provide patients and customers access to innovative diagnostic and therapeutic solutions.Cyclopharma’s R&D programs, Cyclopharma US, and international development projects will be transferred to a new company owned by Denos, Cyclopharma’s historical shareholder. Future inventors of treatments against the cancer or pioneers of biomimicry, here is the portraits of these "made in Auvergne "biotech talents.CARBIOS is an innovative green chemistry company specializing in breakthrough technologies dedicated to the recovery of plastic waste and the production of bio-polymers. Services of measure, study, development and training, Calnesis supplies to its customers its expertise as for the measure of the physical-chemical variables necessary for their industrial applications. You wish to develop your project of biotechnology start-up: take part to the New Deal Biotech competition!